Skip to content
Is There Anything GLP-1s Can’t Do? episode artwork

Nov 19, 2025 1 hr 6 min

Is There Anything GLP-1s Can’t Do?

from Aspen Ideas to Go Hosted by The Aspen Institute

Weight loss and diabetes drugs in the class called GLP-1s have exploded onto the market, starting to put a real dent in the obesity epidemic. And as doctors are gathering more data, it looks like the medications may also provide real benefits for cardiac health, liver disease, kidney function and possibly even addiction and sleep disorders. In this episode, a panel of experts explains how the drugs work, why they’ve been so effective, and how hopeful we might be about other uses. Cedars Sinai cardiologist Martha Gulati joins Nora Volkow, the director of the National Institute on Drug Abuse and Diana Thiara, an obesity expert at UCSF, for a forward-looking conversation about this potentially game-changing medical advancement. Time Magazine health reporter Alice Park moderates the conversation.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Is There Anything GLP-1s Can’t Do?

0:00 1:06:55

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Aspen Ideas to Go?

This episode is 1 hour and 6 minutes long.

When was this Aspen Ideas to Go episode published?

This episode was published on November 19, 2025.

Can I download this Aspen Ideas to Go episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.